Market Tracker

02/23 5:15pm ET

Immunomedics Inc (NASDAQ:IMMU)

17.01
Delayed Data
As of Feb 23
 +0.64 / +3.91%
Today’s Change
4.73
Today|||52-Week Range
18.93
+5.26%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close16.37
Today’s open16.47
Day’s range16.24 - 17.25
Volume2,483,422
Average volume (3 months)3,004,499
Market cap$2.8B
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+28.12%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp+0.23+0.53%
--Quidel Corp-2.22-5.98%
MYGNMyriad Genetics Inc+0.44+1.35%
----
Data as of 4:00pm ET, 02/23/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Michael Pehl
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts